# Medtronic Resolute Onyx 2.0 mm Clinical Study

Study · id `cardio:ct-nct02412501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02412501](<https://clinicaltrials.gov/study/NCT02412501>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02412501

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

## Technical summary

Registry record NCT02412501. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04-06 (actual); primary completion 2017-02-13 (actual). Results posted on 2018-04-10.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Started: 2015-04-06 (actual) (ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Primary completion: 2017-02-13 (actual) (ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Completion: 2019-02-21 (actual) (ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Results first posted: 2018-04-10 (ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02412501, source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02412501-2019-07-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Medtronic Resolute Onyx 2.0 mm Clinical Study
- Condition: Coronary Artery Disease
- Intervention (Device): Resolute Onyx Stent - 2.0 mm
- Lead sponsor: Medtronic Vascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Vascular (`cardio:org-medtronic-vascular`)

## Provenance

Content hash: 5757cfe699de561bd45d8a8782c28012ecd3acc080ed67e7db01ababeeb60c31
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
